Stemline Therapeutics Inc (NASDAQ:STML)

15.75
Delayed Data
As of 3:59pm ET
 -0.15 / -0.94%
Today’s Change
10.50
Today|||52-Week Range
26.99
-7.68%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 50.00, with a high estimate of 55.00 and a low estimate of 49.00. The median estimate represents a +217.46% increase from the last price of 15.75.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.60
Sales
$156.4K
Reporting Date
Mar 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.52%
 
 
 
 
 
 
Growthannually 2.27%
 
 
 
 

Sales

Growthquarterly 118.96%
 
 
 
 
 
 
Growthannually 388.97%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account